Aemetis (NASDAQ:AMTX) Shares Cross Below Two Hundred Day Moving Average – What’s Next?

Aemetis, Inc (NASDAQ:AMTX) shares crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $2.05 and traded as low as $1.7324. Aemetis shares last traded at $1.76, with a volume of 811,703 shares traded.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of Aemetis in a research note on Monday, April 20th. Ascendiant Capital Markets raised their price objective on Aemetis from $21.00 to $22.00 and gave the stock a “buy” rating in a research note on Friday, May 22nd. Wall Street Zen downgraded Aemetis from a “hold” rating to a “sell” rating in a report on Saturday, June 6th. Finally, Loop Capital set a $1.75 target price on Aemetis in a research report on Thursday, March 12th. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $11.88.

Aemetis Price Performance

The company has a market capitalization of $112.59 million, a PE ratio of -1.34 and a beta of 1.44. The firm’s fifty day simple moving average is $2.18 and its 200 day simple moving average is $2.04.

Aemetis (NASDAQ:AMTX) last released its quarterly earnings data on Thursday, May 7th. The specialty chemicals company reported ($0.33) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.06). The business had revenue of $54.62 million during the quarter, compared to analyst estimates of $66.70 million. On average, equities research analysts anticipate that Aemetis, Inc will post -1.11 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the stock. Royal Bank of Canada boosted its position in Aemetis by 10,632.5% in the 1st quarter. Royal Bank of Canada now owns 8,908 shares of the specialty chemicals company’s stock worth $28,000 after purchasing an additional 8,825 shares in the last quarter. Sanctuary Advisors LLC purchased a new position in shares of Aemetis during the 1st quarter valued at approximately $33,000. Creative Planning acquired a new position in shares of Aemetis in the 2nd quarter valued at $30,000. Prairiewood Capital LLC acquired a new position in shares of Aemetis in the 1st quarter valued at $47,000. Finally, Bank of America Corp DE boosted its holdings in Aemetis by 62.6% during the third quarter. Bank of America Corp DE now owns 38,526 shares of the specialty chemicals company’s stock worth $87,000 after buying an additional 14,836 shares in the last quarter. 27.02% of the stock is owned by institutional investors and hedge funds.

About Aemetis

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.